What is the most common type of renal cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Renal Cancer

Renal cell carcinoma (RCC) is the most common type of kidney cancer, accounting for approximately 80-90% of all renal malignancies, with clear cell RCC (ccRCC) being the predominant histological subtype. 1

Epidemiological Context

  • RCC represents the 7th most common cancer in men and the 10th most common cancer in women, accounting for approximately 5% and 3% of all adult malignancies respectively 1
  • Among all kidney cancers (which include both renal parenchymal tumors and urothelial cancer of the renal pelvis), RCC specifically accounts for approximately 80% of cases 1
  • The remaining 10-20% of kidney cancers include urothelial carcinomas of the renal pelvis and other rare malignancies 1

Histological Subtypes of RCC

The major histological subtypes with ≥5% incidence include: 1

  • Clear cell RCC (ccRCC): The most common subtype, accounting for the majority of RCC cases and responsible for most kidney cancer-related deaths 1
  • Papillary RCC (pRCC): The second most common subtype 1
  • Chromophobe RCC (chRCC): The third major subtype 1

Less Common Subtypes

  • Rare subtypes each account for ≤1% of total incidence and include collecting duct, medullary, and other variants 1
  • Unclassified RCC (uRCC) represents approximately 4% of cases when tumors do not fit established diagnostic criteria 1

Clinical Significance

  • In metastatic disease, clear cell histology predominates even more dramatically, representing 83-88% of cases 1
  • Due to the overwhelming predominance of clear cell histology in advanced disease, non-clear cell RCC subtypes are often grouped together as "nccRCC" for clinical trial feasibility 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.